rs2256543

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000849678.1(POLR1HASP):​n.589-23140A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.596 in 151,194 control chromosomes in the GnomAD database, including 27,132 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 27132 hom., cov: 29)

Consequence

POLR1HASP
ENST00000849678.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.24

Publications

35 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000849678.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.724 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000849678.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1HASP
ENST00000849678.1
n.589-23140A>G
intron
N/A
POLR1HASP
ENST00000849679.1
n.65+6547A>G
intron
N/A
POLR1HASP
ENST00000849680.1
n.506-13306A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.596
AC:
90000
AN:
151086
Hom.:
27084
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.611
Gnomad AMI
AF:
0.517
Gnomad AMR
AF:
0.637
Gnomad ASJ
AF:
0.642
Gnomad EAS
AF:
0.743
Gnomad SAS
AF:
0.637
Gnomad FIN
AF:
0.562
Gnomad MID
AF:
0.592
Gnomad NFE
AF:
0.567
Gnomad OTH
AF:
0.602
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.596
AC:
90087
AN:
151194
Hom.:
27132
Cov.:
29
AF XY:
0.598
AC XY:
44157
AN XY:
73898
show subpopulations
African (AFR)
AF:
0.611
AC:
24965
AN:
40830
American (AMR)
AF:
0.637
AC:
9691
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.642
AC:
2227
AN:
3470
East Asian (EAS)
AF:
0.743
AC:
3825
AN:
5146
South Asian (SAS)
AF:
0.640
AC:
3081
AN:
4814
European-Finnish (FIN)
AF:
0.562
AC:
5905
AN:
10516
Middle Eastern (MID)
AF:
0.592
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
0.567
AC:
38501
AN:
67906
Other (OTH)
AF:
0.598
AC:
1253
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1835
3670
5504
7339
9174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.578
Hom.:
76931
Bravo
AF:
0.603
Asia WGS
AF:
0.607
AC:
2090
AN:
3448

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
3.0
DANN
Benign
0.35
PhyloP100
-2.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2256543;
hg19: chr6-29937833;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.